➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Merck
Medtronic
Colorcon
Boehringer Ingelheim

Last Updated: October 16, 2021

DrugPatentWatch Database Preview

Nimodipine - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic sources for nimodipine and what is the scope of freedom to operate?

Nimodipine is the generic ingredient in three branded drugs marketed by Bionpharma Inc, Heritage Pharms Inc, Sofgen Pharms, Sun Pharm Inds Inc, Thepharmanetwork Llc, Bayer Pharms, and Arbor Pharms Llc, and is included in seven NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Nimodipine has two patent family members in two countries.

There are eight drug master file entries for nimodipine. Seven suppliers are listed for this compound.

Summary for nimodipine
Drug Prices for nimodipine

See drug prices for nimodipine

Recent Clinical Trials for nimodipine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University Health Network, TorontoEarly Phase 1
Medical University of ViennaPhase 2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Phase 2

See all nimodipine clinical trials

Pharmacology for nimodipine
Medical Subject Heading (MeSH) Categories for nimodipine

US Patents and Regulatory Information for nimodipine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Inc NIMODIPINE nimodipine CAPSULE;ORAL 077067-001 Apr 17, 2007 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Bionpharma Inc NIMODIPINE nimodipine CAPSULE;ORAL 076740-001 Jan 17, 2008 AB RX No Yes ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Thepharmanetwork Llc NIMODIPINE nimodipine CAPSULE;ORAL 090103-001 Apr 7, 2014 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Arbor Pharms Llc NYMALIZE nimodipine SOLUTION;ORAL 203340-002 Apr 8, 2020 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Arbor Pharms Llc NYMALIZE nimodipine SOLUTION;ORAL 203340-002 Apr 8, 2020 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Arbor Pharms Llc NYMALIZE nimodipine SOLUTION;ORAL 203340-002 Apr 8, 2020 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for nimodipine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988 ⤷  Free Forever Trial ⤷  Free Forever Trial
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988 ⤷  Free Forever Trial ⤷  Free Forever Trial
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988 ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Merck
Medtronic
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.